Grace Norman and Mark Weiss Earlier this year, when the then EU (Withdrawal) Bill was debated at length in the House of Lords, the Faculty of Public Health found itself […]
Latest articles
Tony Rao: Calling time on dumbing down our drinking culture
If we cannot rely on our government to observe the principle of being at “arm’s length” from the drinks industry, we wander into a storm that has the potential to […]
Junaid Nabi and Quoc-Dien Trinh: How not to talk about racial disparities in cancer outcomes
Stereotypical narratives can harm efforts to address racial disparities in cancer outcomes, say Junaid Nabi and Quoc-Dien Trinh […]
Maria Kristiansen: The difference that kind and compassionate care makes
Doctors’ acts of kindness and compassionate care shaped my experience of bereavement, says Maria Kristiansen […]
Zackary Berger’s journal reviews—17 September 2018
Zackary Berger reviews the latest research from the top medical journals […]
Trish Greenhalgh: The Cochrane Collaboration—what crisis?
Maintaining—and funding—the ‘view from nowhere’ requires delicate navigation of tricky political spaces and sometimes accepting hard-won compromises […]
Ray Moynihan: Let’s stop the burning and the bleeding at Cochrane—there’s too much at stake
To see the future of Cochrane threatened foreshadows a disaster for all of us […]
Richard Smith: What to do with the £20 billion promised to the NHS?
Under great political pressure and caught up in the razzmatazz surrounding the NHS’s 70th birthday, the government has promised another £20 billion to the NHS. What should be done with […]
Helen Macdonald: Should clinicians spend more time thinking about guidelines than evidence?
Old evidence based medicine (EBM) is dead, and clinicians need to get to grips with guidelines as the power tools of EBM. Digitially structured data could improve guidelines. And, with […]
Jeffrey Aronson: When I use a word . . . Liquorice and glycyrrhetinic acid
As I described two weeks ago, phenylbutazone was the first marketed compound to be later classified as a non-steroidal anti-inflammatory drug. However, the first drug to be so described seems […]